KRONOS WORLDWIDE INC (KRO)

US50105F1057 - Common Stock

12.91  +0.13 (+1.02%)

After market: 12.91 0 (0%)

Fundamental Rating

3

KRO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. The financial health of KRO is average, but there are quite some concerns on its profitability. KRO is valied quite expensively at the moment, while it does show a decent growth rate. KRO also has an excellent dividend rating.



2

1. Profitability

1.1 Basic Checks

In the past year KRO has reported negative net income.
In the past year KRO had a positive cash flow from operations.
KRO had positive earnings in 4 of the past 5 years.
KRO had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

KRO has a worse Return On Assets (-2.67%) than 71.43% of its industry peers.
With a Return On Equity value of -6.07%, KRO is not doing good in the industry: 73.81% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.67%
ROE -6.07%
ROIC N/A
ROA(3y)2.78%
ROA(5y)3.18%
ROE(3y)5.94%
ROE(5y)7.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

KRO has a Gross Margin of 9.89%. This is amonst the worse of the industry: KRO underperforms 84.52% of its industry peers.
In the last couple of years the Gross Margin of KRO has declined.
The Profit Margin and Operating Margin are not available for KRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.71%
GM growth 5Y-21.8%

4

2. Health

2.1 Basic Checks

KRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KRO has less shares outstanding
Compared to 5 years ago, KRO has less shares outstanding
Compared to 1 year ago, KRO has a worse debt to assets ratio.

2.2 Solvency

KRO has an Altman-Z score of 1.96. This is not the best score and indicates that KRO is in the grey zone with still only limited risk for bankruptcy at the moment.
KRO's Altman-Z score of 1.96 is in line compared to the rest of the industry. KRO outperforms 47.62% of its industry peers.
KRO has a Debt/Equity ratio of 0.55. This is a neutral value indicating KRO is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.55, KRO perfoms like the industry average, outperforming 54.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z 1.96
ROIC/WACCN/A
WACC7.7%

2.3 Liquidity

A Current Ratio of 3.01 indicates that KRO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.01, KRO is in the better half of the industry, outperforming 77.38% of the companies in the same industry.
KRO has a Quick Ratio of 1.49. This is a normal value and indicates that KRO is financially healthy and should not expect problems in meeting its short term obligations.
KRO has a Quick ratio (1.49) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.01
Quick Ratio 1.49

4

3. Growth

3.1 Past

KRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -147.78%.
The Revenue for KRO has decreased by -13.66% in the past year. This is quite bad
KRO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.06% yearly.
EPS 1Y (TTM)-147.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.22%
Revenue 1Y (TTM)-13.66%
Revenue growth 3Y0.56%
Revenue growth 5Y0.06%
Sales Q2Q%16.85%

3.2 Future

The Earnings Per Share is expected to grow by 59.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.08% on average over the next years. This is quite good.
EPS Next Y192.78%
EPS Next 2Y93.34%
EPS Next 3Y59.83%
EPS Next 5YN/A
Revenue Next Year19.24%
Revenue Next 2Y13.5%
Revenue Next 3Y11.08%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KRO. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 32.36, which means the current valuation is very expensive for KRO.
KRO's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. KRO is more expensive than 71.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 19.93, KRO is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 32.36

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
KRO's earnings are expected to grow with 59.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.34%
EPS Next 3Y59.83%

8

5. Dividend

5.1 Amount

KRO has a Yearly Dividend Yield of 5.95%, which is a nice return.
KRO's Dividend Yield is rather good when compared to the industry average which is at 3.10. KRO pays more dividend than 92.86% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, KRO pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.95%

5.2 History

The dividend of KRO has a limited annual growth rate of 2.22%.
KRO has paid a dividend for at least 10 years, which is a reliable track record.
KRO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.22%
Div Incr Years0
Div Non Decr Years11

5.3 Sustainability

The earnings of KRO are negative and hence is the payout ratio. KRO will probably not be able to sustain this dividend level.
The dividend of KRO is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-178.21%
EPS Next 2Y93.34%
EPS Next 3Y59.83%

KRONOS WORLDWIDE INC

NYSE:KRO (5/24/2024, 7:04:00 PM)

After market: 12.91 0 (0%)

12.91

+0.13 (+1.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.49B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 5.95%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 32.36
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.67%
ROE -6.07%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 9.89%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.01
Quick Ratio 1.49
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-147.78%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y192.78%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.66%
Revenue growth 3Y0.56%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y